Intrinsiqq
Capricor Therapeutics Inc. logo

Capricor Therapeutics Inc.

CAPR

Compare

Valuation & Multiples

Based on TTM earnings · Diluted shares

Market Cap$523M
EPS-$2.45
P/E-3.67
P/FCF-4.55
EV/EBITDA-2.78
FCF Yield–
Div. Yield–
Net Debt/FCF1.3x
Capricor Therapeutics Inc. intrinsic value
52-Week Range
$3.85$26.92

Profitability & Returns

Revenue (FY)

$0.00

▼ -100.0% YoY

Net Income (TTM)

-$129M

▼ -159.6% YoY

Op. Margin

–

ROIC

-40.70%

▲ +2.6pp YoY

Cash Flow & Balance Sheet

FCF (TTM)

-$115M

▼ -76.7% YoY

Op. Cash Flow (TTM)

-$104M

▼ -74.5% YoY

Net Debt

-$147M

Net Cash Position

Cash & Equiv.

$238M

Continue Research

Peers

Pharmaceutical Preparations · Pick stocks to compare with CAPR

CompareIntrinsic value
PRLDPrelude Therapeutics Incorporated
$3.60+1.27%40
JANXJanux Therapeutics Inc.
$17.63+9.78%40
BGMBGM Group Ltd.
$8.25-8.33%26
SLGLSol-Gel Technologies Ltd.
$61.01-3.17%65
SCYXScynexis, Inc.
$3.50+6.06%40
CELUCelularity Inc.
$0.76+4.83%0
CTMXCytomX Therapeutics Inc.
$2.19+2.34%10
QUREuniQure N.V.
$21.70+3.28%10

Held by ETFs

CAPR is in 16 US ETFs. The largest of them, with CAPR's weight in each:

Capricor Therapeutics (CAPR) in three numbers

Quality score
10/100
Best check: net debt, -$147M. Weakest: return on capital, -40.7%.
Quality
Dividend
None
No dividend in the SEC filings we hold.
Dividends
P/E
-3.67
Negative: a loss over the last twelve months. Price to free cash flow -4.55.
Financials

Questions about Capricor Therapeutics

Is Capricor Therapeutics a high-quality business?

Capricor Therapeutics scores 10 out of 100 on Intrinsiqq's quality score, which makes it a lower-quality business on these measures. The score blends 4 checks computed from SEC filings. Its best check is net debt at -$147M, and its weakest is return on capital at -40.7%. The Quality tab shows every check against its target.

Does Capricor Therapeutics (CAPR) pay a dividend?

No. Capricor Therapeutics (CAPR) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.

Source: 10-Q filed 13 Aug 2026 (period ending 30 Jun 2026), SEC. Price: last close 6 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.

Spot a number that looks wrong? Check it in CAPR's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing CAPR

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.